Cargando…

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Detalles Bibliográficos
Autores principales:	Mohamed-Hussein, Aliae A.R., Aly, Karim M.E., Ibrahim, Mohamed-Eltaher A.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834233/ https://www.ncbi.nlm.nih.gov/pubmed/32531536 http://dx.doi.org/10.1016/j.mehy.2020.109975

Ejemplares similares

Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot study
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2022)

Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities
por: Mohamed Hussein, Aliae AR, et al.
Publicado: (2021)

COVID‐19 coagulopathy – what should we treat?
por: Chowdary, Pratima
Publicado: (2022)

Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
por: Elbeddini, Ali, et al.
Publicado: (2020)

Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2022)

COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
por: Zheng, Runhui, et al.
Publicado: (2021)

Short-term evaluation of motor and sensory nerve conduction parameters in COVID-19-associated peripheral neuropathy patients
por: Shaddad, Ahmad M., et al.
Publicado: (2023)

Prevalence and early outcome of bronchiectasis as an atypical presentation in COVID-19 patients
por: Hussein, Aliae A. R. Mohamed, et al.
Publicado: (2022)

Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
por: Hussein, Aliae A. R. Mohamed, et al.
Publicado: (2023)

Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis
por: Sunseri, Maria, et al.
Publicado: (2018)

COVID-19 Associated Coagulopathy and Thrombotic Complications
por: Mezalek, Zoubida Tazi, et al.
Publicado: (2020)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Coagulopathy and COVID-19
por: Lorini, Ferdinando Luca, et al.
Publicado: (2021)

Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021)

The clinical and functional characteristics of bronchiectasis among tuberculosis patients in Upper Egypt: a single-center study
por: Hashem, Maiada K., et al.
Publicado: (2022)

To what extent AstraZeneca ChAdOx1 nCoV-19 vaccine is safe and effective? Rapid systematic review
por: Mohamed Hussein, Aliae A. R., et al.
Publicado: (2022)

Sudden hoarseness of voice in COVID-19 patient
por: Mohamed-Hussein, Aliae Abd-Rabou, et al.
Publicado: (2021)

The burden of COVID-19 pandemic on tuberculosis detection: a single-center study
por: Hashem, Maiada K., et al.
Publicado: (2022)

Thrombosis and Coagulopathy in COVID-19
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

Acceptance of COVID-19 vaccines among medical teams in Egypt
por: Mohamed Hussein, Aliae A.R., et al.
Publicado: (2021)

Covid-19-induced coagulopathy and observed benefits with anticoagulation
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

COVID-19-induced coagulopathy: Experience, achievements, prospects
por: Dubey, Leonid, et al.
Publicado: (2022)

The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis
por: Smith, Tom, et al.
Publicado: (2014)

Understanding COVID-19-associated coagulopathy
por: Conway, Edward M., et al.
Publicado: (2022)

Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
por: Abdel-Maboud, Mohamed, et al.
Publicado: (2020)

Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations
por: Rao, Gundu H. R., et al.
Publicado: (2012)

Comparison of the coagulopathies associated with COVID‐19 and sepsis
por: Campbell, Robert A., et al.
Publicado: (2021)

Prescribing Aspirin for Preeclampsia Prevention in Pregnant Women During COVID-19: Should or Shouldn’t?
por: Eslamian, Laleh, et al.
Publicado: (2021)

Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview
por: Kushimoto, Shigeki, et al.
Publicado: (2017)

COVID-19 pandemic: perception, attitude, and practices of university students from health sector faculties
por: Osman, Basma Mohamed, et al.
Publicado: (2023)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020)

The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)

COVID-19 Related Arterial Coagulopathy
por: Singh, Gagandeep, et al.
Publicado: (2020)

COVID-19 coagulopathy: an evolving story
por: The Lancet Haematology
Publicado: (2020)

COVID-19 : coagulopathie et thrombose
por: Tazi Mezalek, Z.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s0haiokqdgu23d0oa6vuma8s6g